Additionally, significant contributions were observed from certain SNPs located predominantly in genes such as PNPLA3, TM6SF2, and GCKR, which mainly play a role in liver fat accumulation and are associated with an elevated risk of NAFLD. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.